Stability-indicating spectrophotometric quantification of safinamide in the presence of its possible degradation product
Abstract In recent times, a truly exquisite pharmaceutical marvel has graced the world of medicine, known as Safinamide (SAF). This opulent creation has been specifically tailored to cater to the needs of individuals afflicted with Parkinson’s disease (PD), an esteemed neurological condition renowne...
Saved in:
| Main Authors: | Ebraam B. Kamel, Omar M El-Abassy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-83195-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sustainable UV approaches backed by one step extraction procedure for quantifying the newly released mirabegron and silodosin mixture in urine
by: Ahmed R. Mohamed, et al.
Published: (2025-08-01) -
Use of safinamide for treatment of Parkinson disease: real-world data from Spain
by: María Isabel Morales Casado, et al.
Published: (2025-07-01) -
Long-Term Real-World Experience with Safinamide in Patients with Parkinson’s Disease
by: Anna Planas-Ballvé, et al.
Published: (2024-12-01) -
A novel stability-indicating chromatographic quantification of the antiparkinsonian drug safinamide in its pharmaceutical formulation employing HPTLC densitometry and ion-pair HPLC–DAD
by: Engy A. Ibrahim, et al.
Published: (2024-11-01) -
Eco-friendly spectrophotometric quantification of the potential combination of mirabegron and tamsulosin
by: Omar M El-Abassy, et al.
Published: (2025-06-01)